Back to search

Article

An optimized “hypoxia in a pill” regimen reverses neurodegenerative disease phenotypes in multiple preclinical models

2026-07-03

Abstract excerpt

A growing body of pre-clinical research has demonstrated the therapeutic potential of chronic, continuous hypoxia (11% FIO2) for treating both rare and common forms of neurodegeneration (1). However, the chronic delivery of hypoxic gas poses both practical challenges and long-term safety concerns. We previously introduced a small molecule, “hypoxia-in-a-pill” regimen that combines the hemoglobin affinity enhancer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
55cd54d3-c419-5042-bbd7-b3a594c8e50e
DOI
10.64898/2026.06.30.734089
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An optimized “hypoxia in a pill” regimen reverses neurodegenerative disease phenotypes in multiple preclinical modelsDOI 10.64898/2026.06.30.734089
Select a neighboring publication to make it the new centre.